Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia - Biogen ( NASDAQ:BIIB )
Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorder BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
India's strong fiscal dynamics to propel growth, curb inflation: Report - ETCFO
India's fiscal dynamics have improved at the aggregate level post-pandemic, with a most notable shift in the quality of spending, which is reflected in the higher capital expenditure by the government over the last five years, according to a Morgan Stanley report.
XRP News: Martini Market, The First Decentralized Prediction Markets On XRP Announces Its MRT Token Presale
DUBAI, United Arab Emirates, June 18, 2025 ( GLOBE NEWSWIRE ) -- The XRP Ledger ( XRPL ) is entering a new financial frontier and Martini Market is leading the way as the first decentralized prediction market built natively on XRPL, Martini Market is poised to transform the ecosystem by ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Napco Security Technologies - NAPCO Security Techs ( NASDAQ:NSSC )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Napco To Contact Him Directly To Discuss Their Options
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Arvinas ( NASDAQ:ARVN ) , Merck & Co ( NYSE:MRK )
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoubleVerify - DoubleVerify Holdings ( NYSE:DV )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In DoubleVerify To Contact Him Directly To Discuss Their Options
Global millionaire ranks to swell by 5 million over next 5 years, UBS says
The world is expected to add more than 5 million millionaires in the next five years as global wealth grew for a second straight year, according to the latest UBS Global Wealth Report. "This trend [of rising wealth] is expected to show up not only in rising total personal wealth, but also in a ...
Forbes Recognizes Beacon College on Accessibility 100 List
Leesburg, Florida, June 18, 2025 ( GLOBE NEWSWIRE ) -- Recognized nationally as the preeminent institution for educating students who learn differently, Beacon College now has earned a prestigious spot on Forbes's inaugural Accessibility 100 list.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources - Civitas Resources ( NYSE:CIVI )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Civitas To Contact Him Directly To Discuss Their Options
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction - Prenetics Global ( NASDAQ:PRE )
Bolsters Prenetics' pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 million Prenetics simplifies investment thesis as company focuses on high-growth consumer health brands IM8, CircleDNA, and Europa
